Differences in serum microRNA profiles in hepatitis B and C virus infection

Journal of Infection

Volumn 70, Issue 3, 2015, Pages 273-287

  Akamatsu, Sakura ^a,b   Hayes, C Nelson ^a,b   Tsuge, Masataka ^a   Miki, Daiki ^a,b   Akiyama, Rie ^a,b   Abe, Hiromi ^a,b   Ochi, Hidenori ^a,b   Hiraga, Nobuhiko ^a,b   Imamura, Michio ^a,b   Takahashi, Shoichi ^c   Aikata, Hiroshi ^a   Kawaoka, Tomokazu ^a,b   Kawakami, Yoshiiku ^a,b   Ohishi, Waka ^d   Chayama, Kazuaki ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c Koyo New Town Hospital   (Japan)

^d RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

HBeAg; Microarray; MicroRNA; MiR 122; MiR 125b; Serum biomarkers

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MICRORNA; MICRORNA 122; MICRORNA 125B; MICRORNA 22; PROTEIN MIR 1275; PROTEIN MIR 720; PROTEIN MIR 99A; RNA; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION; VALIDATION STUDY; VERY ELDERLY; BLOOD; CHRONIC HEPATITIS C; DOWN REGULATION; GENETICS; HEPACIVIRUS; HEPATITIS B VIRUS; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPACIVIRUS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION; YOUNG ADULT;

EID: 84922809223     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.10.017     Document Type: Article

References (56)

1. Fields B.N., Knipe D.M., Howley P.M. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th ed.
2. McMahon B.J. The natural history of chronic hepatitis B virus infection. Hepatology 2009 May, 49(5 Suppl):S45-S55. [Consensus Development Conference, NIH Research Support, U.S. Gov't, P.H.S.].
3. Brechot C., Kremsdorf D., Soussan P., Pineau P., Dejean A., Paterlini-Brechot P., et al. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. Pathol Biol (Paris) 2010 Aug, 58(4):278-287. [Review].
4. Xi Y., Nakajima G., Gavin E., Morris C.G., Kudo K., Hayashi K., et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007 Oct, 13(10):1668-1674. [Research Support, N.I.H., Extramural].
5. Liu A.M., Zhang C., Burchard J., Fan S.T., Wong K.F., Dai H., et al. Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma. Omics 2011 Mar, 15(3):187-191.
6. Bala S., Marcos M., Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009 Dec 7, 15(45):5633-5640. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review].
7. Ji F., Yang B., Peng X., Ding H., You H., Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 2011 Jul, 18(7):e242-e251. [Research Support, Non-U.S. Gov't].
8. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U. S. A. 2008 Jul 29, 105(30):10513-10518. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
9. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009 Apr, 49(4):1098-1112.
10. Hayes C.N., Akamatsu S., Tsuge M., Miki D., Akiyama R., Abe H., et al. Hepatitis B virus-specific miRNAs and argonaute2 play a role in the viral life cycle. PLoS One 2012, 7(10):e47490. [Research Support, Non-U.S. Gov't].
11. Shwetha S., Gouthamchandra K., Chandra M., Ravishankar B., Khaja M.N., Das S. Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis. Sci Rep 2013 Apr, 3(3):1555. [Research Support, Non-U.S. Gov't].
12. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011 Sep 1, 39(16):7223-7233. [Research Support, Non-U.S. Gov't].
13. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U. S. A 2011 Mar 22, 108(12):5003-5008. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
14. Novellino L., Rossi R.L., Bonino F., Cavallone D., Abrignani S., Pagani M., et al. Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs. PLoS One 2012, 7(3):e31952.
15. Gallo A., Tandon M., Alevizos I., Illei G.G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012, 7(3):e30679. [Comparative Study Research Support, N.I.H., Intramural].
16. Huang X., Yuan T., Tschannen M., Sun Z., Jacob H., Du M., et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 2013, 14:319. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
17. Conde-Vancells J., Rodriguez-Suarez E., Embade N., Gil D., Matthiesen R., Valle M., et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res 2008 Dec, 7(12):5157-5166. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
18. Li J., Liu K., Liu Y., Xu Y., Zhang F., Yang H., et al. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat Immunol 2013 Aug, 14(8):793-803. [Research Support, Non-U.S. Gov't].
19. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994 Jun, 19(6):1513-1520. [Review].
20. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inf 2011 Oct, 44(5):839-847. [Research Support, Non-U.S. Gov't].
21. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012 Jan, 40(Database issue):D1241-D1244. [Research Support, Non-U.S. Gov't].
22. Vartanian J.P., Henry M., Marchio A., Suspene R., Aynaud M.M., Guetard D., et al. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog 2010 May, 6(5):e1000928. [Research Support, Non-U.S. Gov't].
23. Yang J.H., Li J.H., Jiang S., Zhou H., Qu L.H. ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res 2013 Jan, 41(Database issue):D177-D187. [Research Support, Non-U.S. Gov't].
24. Lum G., Gambino S.R. Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone. Clin Chem 1972 Apr, 18(4):358-362.
25. Bala S., Petrasek J., Mundkur S., Catalano D., Levin I., Ward J., et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012 Nov, 56(5):1946-1957. [Research Support, N.I.H., Extramural].
26. Arataki K., Hayes C.N., Akamatsu S., Akiyama R., Abe H., Tsuge M., et al. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. J Med Virology 2013 May, 85(5):789-798. [Research Support, Non-U.S. Gov't].
27. Wang S., Qiu L., Yan X., Jin W., Wang Y., Chen L., et al. Loss of MiR-122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1 modulated P53 activity. Hepatology 2012 Mar, 55(3):730-741.
28. Hu J., Xu Y., Hao J., Wang S., Li C., Meng S. MiR-122 in hepatic function and liver diseases. Protein Cell 2012 May, 3(5):364-371.
29. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004 Jul, 1(2):106-113. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
30. Chen Y., Shen A., Rider P.J., Yu Y., Wu K., Mu Y., et al. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. Faseb J 2011 Dec, 25(12):4511-4521.
31. Qiu L., Fan H., Jin W., Zhao B., Wang Y., Ju Y., et al. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 2010 Aug 6, 398(4):771-777. [Research Support, Non-U.S. Gov't].
32. Potenza N., Papa U., Mosca N., Zerbini F., Nobile V., Russo A. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 2011 Jul, 39(12):5157-5163.
33. Zhang G.L., Li Y.X., Zheng S.Q., Liu M., Li X., Tang H. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antivir Res 2010 Nov, 88(2):169-175. [Research Support, Non-U.S. Gov't].
34. Li D., Liu X., Lin L., Hou J., Li N., Wang C., et al. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 2011 Oct 21, 286(42):36677-36685. [Research Support, Non-U.S. Gov't].
35. Takata A., Otsuka M., Kojima K., Yoshikawa T., Kishikawa T., Yoshida H., et al. MicroRNA-22 and microRNA-140 suppress NF-kappaB activity by regulating the expression of NF-kappaB coactivators. Biochem Biophys Res Commun 2011 Aug 12, 411(4):826-831. [Research Support, Non-U.S. Gov't].
36. Xu D., Takeshita F., Hino Y., Fukunaga S., Kudo Y., Tamaki A., et al. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 2011 Apr 18, 193(2):409-424. [Research Support, Non-U.S. Gov't].
37. Shi C., Xu X. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma. Biomed Pharmacother 2013 Jun, 67(5):375-380. [Research Support, Non-U.S. Gov't].
38. Bandiera S., Ruberg S., Girard M., Cagnard N., Hanein S., Chretien D., et al. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One 2011, 6(6):e20746.
39. D'Agostino D.M., Bernardi P., Chieco-Bianchi L., Ciminale V. Mitochondria as functional targets of proteins coded by human tumor viruses. Adv Cancer Res 2005, 94:87-142.
40. Li L.Z., Zhang C.Z., Liu L.L., Yi C., Lu S.X., Zhou X., et al. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. Carcinogenesis 2014 Feb, 35(2):469-478. [Comparative Study Research Support, Non-U.S. Gov't].
41. Schopman N.C., Heynen S., Haasnoot J., Berkhout B. A miRNA-tRNA mix-up: tRNA origin of proposed miRNA. RNA Biol 2010 Sep-Oct; 7(5):573-576. [Research Support, Non-U.S. Gov't].
42. Ou J.H., Laub O., Rutter W.J. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U. S. A 1986 Mar, 83(6):1578-1582. [Research Support, U.S. Gov't, P.H.S.].
43. Garcia P.D., Ou J.H., Rutter W.J., Walter P. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 1988 Apr, 106(4):1093-1104. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
44. Milich D., Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003 Nov, 38(5):1075-1086. [Review].
45. Lang T., Lo C., Skinner N., Locarnini S., Visvanathan K., Mansell A. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol 2011 Oct, 55(4):762-769. [Research Support, Non-U.S. Gov't].
46. Wu S., Kanda T., Imazeki F., Nakamoto S., Tanaka T., Arai M., et al. Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression. J Infect Dis 2012 Aug 1, 206(3):415-420. [Research Support, Non-U.S. Gov't].
47. Tong S., Kim K.H., Chante C., Wands J., Li J. Hepatitis B Virus e Antigen Variants. Int J Med Sci 2005, 2(1):2-7.
48. Nguyen D.H., Hu J. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids. J Virol 2008 Jul, 82(14):6852-6861. [Research Support, N.I.H., Extramural].
49. Warner B.G., Abbott W.G., Rodrigo A.G. Frequency-dependent selection drives HBeAg seroconversion in chronic hepatitis B virus infection. Evol Med Public Health 2014 Jan, 2014(1):1-9.
50. Winther T.N., Bang-Berthelsen C.H., Heiberg I.L., Pociot F., Hogh B. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One 2013, 8(3):e58236. [Research Support, Non-U.S. Gov't].
51. Johnston M., Geoffroy M.C., Sobala A., Hay R., Hutvagner G. HSP90 protein stabilizes unloaded argonaute complexes and microscopic P-bodies in human cells. Mol Biol Cell 2010 May 1, 21(9):1462-1469. [Research Support, Non-U.S. Gov't].
52. Shim H.Y., Quan X., Yi Y.S., Jung G. Heat shock protein 90 facilitates formation of the HBV capsid via interacting with the HBV core protein dimers. Virology 2011 Feb 5, 410(1):161-169. [Research Support, Non-U.S. Gov't].
53. Liu C., Zhang X., Huang F., Yang B., Li J., Liu B., et al. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10. J Biol Chem 2012 Aug 24, 287(35):29373-29383. [Research Support, N.I.H., Extramural sResearch Support, Non-U.S. Gov't].
54. Zhao D., Wang X., Lou G., Peng G., Li J., Zhu H., et al. APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems. Virus Res 2010 Aug, 151(2):213-219. [Research Support, Non-U.S. Gov't].
55. Gibbings D.J., Ciaudo C., Erhardt M., Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009 Sep, 11(9):1143-1149. [Comment Research Support, Non-U.S. Gov't].
56. Li J., Liu Y., Wang Z., Liu K., Wang Y., Liu J., et al. Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. J Virol 2011 Jul, 85(13):6319-6333. [Research Support, Non-U.S. Gov't].